Design of a 3-Arm Randomized Trial for Posthysterectomy Vault Prolapse Involving Sacral Colpopexy, Transvaginal Mesh, and Native Tissue Apical Repair: The Apical Suspension Repair for Vault Prolapse in a Three-Arm Randomized Trial.


Journal

Female pelvic medicine & reconstructive surgery
ISSN: 2154-4212
Titre abrégé: Female Pelvic Med Reconstr Surg
Pays: United States
ID NLM: 101528690

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 21 12 2019
medline: 25 8 2021
entrez: 21 12 2019
Statut: ppublish

Résumé

The objective of this study was to present the design of the Apical Suspension Repair for Vault Prolapse in a Three-Arm Randomized Trial (ASPIRe), which compares the efficacy and safety of 3 apical repairs: native tissue (NT) transvaginal repair, transvaginal mesh, and sacral colpopexy. Patient selection criteria, primary and secondary outcome measures including patient-reported outcome questionnaires, masking, surgeon certification, procedure standardization, adverse events collection and adjudication, and cost analysis will be described for this multi-centered randomized trial. Given the unique risks/benefits of each technique, a noninferiority design will be used to compare apical transvaginal mesh to mesh sacral colpopexy. A superiority design will be used to compare the 2 mesh repairs to NT transvaginal apical repair. Survival analysis will be used to assess a composite primary outcome for success composed of a subjective measure (no prolapse symptoms), objective measure (no prolapse beyond the hymen), and no prolapse retreatment, with a minimum follow-up of 36 months. Secondary outcome measures collected every 6 months include assessment of validated general and condition-specific quality of life measures, global impression of improvement, satisfaction and regret, body image, and sexual function. Randomization and surgical treatment of 360 participants are complete, and the study is in the follow-up phase. This report will provide valuable insight on the design of a novel 3-arm surgical trial using mesh versus NT to repair vaginal vault prolapse. This trial will provide level 1 evidence on the risks and benefits of mesh augmented versus NT apical repairs.

Identifiants

pubmed: 31860566
doi: 10.1097/SPV.0000000000000803
pmc: PMC7326314
mid: NIHMS1584483
pii: 01436319-202007000-00002
doi:

Banques de données

ClinicalTrials.gov
['NCT02676973']

Types de publication

Clinical Trial Protocol Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

415-424

Subventions

Organisme : NICHD NIH HHS
ID : U10 HD041261
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD054215
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD054214
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD069006
Pays : United States
Organisme : NICHD NIH HHS
ID : U01 HD069031
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD041267
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD054215
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069025
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD069010
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069013
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD054214
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069006
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069010
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD041261
Pays : United States
Organisme : NICHD NIH HHS
ID : U24 HD069031
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD054241
Pays : United States

Références

Am J Obstet Gynecol. 2001 Dec;185(6):1388-95
pubmed: 11744914
Obstet Gynecol. 2011 Nov;118(5):1005-1013
pubmed: 21979458
Int Urogynecol J. 2012 Dec;23(12):1753-61
pubmed: 22531956
Am J Obstet Gynecol. 2012 May;206(5):435.e1-5
pubmed: 22397900
JAMA. 2014 Mar 12;311(10):1023-34
pubmed: 24618964
JAMA. 2013 May 15;309(19):2016-24
pubmed: 23677313
Am J Obstet Gynecol. 2005 May;192(5):1752-8
pubmed: 15902189
Obstet Gynecol. 2009 Feb;113(2 Pt 1):367-73
pubmed: 19155908
Female Pelvic Med Reconstr Surg. 2016 Jul-Aug;22(4):182-9
pubmed: 27054798
Curr Opin Urol. 2012 Jul;22(4):282-6
pubmed: 22617055
Int Urogynecol J Pelvic Floor Dysfunct. 2007 Dec;18(12):1391-3
pubmed: 17934687
Obstet Gynecol. 2004 Oct;104(4):805-23
pubmed: 15458906
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jan;19(1):137-42
pubmed: 17579801
Obstet Gynecol. 2008 Nov;112(5):1131-42
pubmed: 18978116
Med Decis Making. 1996 Jan-Mar;16(1):58-64
pubmed: 8717600
Am J Obstet Gynecol. 2008 May;198(5):575.e1-6
pubmed: 18313632
JAMA. 2018 Apr 17;319(15):1554-1565
pubmed: 29677302
Med Decis Making. 2003 Jul-Aug;23(4):281-92
pubmed: 12926578
Int Urogynecol J. 2015 Jun;26(6):823-30
pubmed: 25516232
JAMA. 1996 Aug 28;276(8):637-9
pubmed: 8773637
Contemp Clin Trials. 2009 Mar;30(2):178-89
pubmed: 19130903
Female Pelvic Med Reconstr Surg. 2012 Jul-Aug;18(4):198-204
pubmed: 22777367
Med Care. 2004 Sep;42(9):851-9
pubmed: 15319610
Cochrane Database Syst Rev. 2013 Apr 30;(4):CD004014
pubmed: 23633316
Arch Gynecol Obstet. 2011 Jun;283(6):1303-7
pubmed: 20544213
Int Urogynecol J. 2013 Nov;24(11):1815-33
pubmed: 24142057

Auteurs

Shawn Menefee (S)

From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Kaiser Permanente San Diego, San Diego, CA.

Holly E Richter (HE)

Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL.

Deborah Myers (D)

Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Brown University, Providence, RI.

Alison Weidner (A)

Division of Urogynecology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC.

Pamela Moalli (P)

Women's Center for Bladder and Pelvic Health, Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh Medical Center, Pittsburgh.

Heidi Harvie (H)

Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Pennsylvania Health System, Philadelphia, PA.

David Rahn (D)

Division of Female Pelvic Medicine and Reconstructive Surgery, University of Texas, Southwestern, Dallas, TX.

Peter Jeppson (P)

Division of Urogynecology, Department of Obstetrics and Gynecology, University of New; Mexico, Albuquerque, NM.

Marie Paraiso (M)

Center for Urogynecology and Reconstructive Pelvic Surgery, Obstetrics, Gynecology and Women's Health Institute, Cleveland Clinic, Cleveland, OH.

Sonia Thomas (S)

RTI International, Research Triangle Park, NC.

Donna Mazloomdoost (D)

Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH